IVD OEM and White-Label Manufacturing: How Private-Label Diagnostics Deals Work

Published

What OEM means in diagnostics

An IVD OEM arrangement is a supply relationship in which the company whose brand appears on the box is not the company that developed or manufactured the chemistry inside it. The buyer-side company (the brand owner) gains a product line without building production; the OEM manufacturer gains volume without building a sales channel. The arrangement is common across clinical chemistry, immunoassay and rapid-test formats, and it is a normal part of the industry rather than a corner case.

OEM, white-label, private label and distribution

Four arrangements are often conflated. A distributor resells the manufacturer's product, usually under the manufacturer's brand, and adds logistics and service. White-label means the OEM's finished product is rebranded and sold largely as-is. Private label is functionally similar but usually implies the brand owner specifies packaging, menu or configuration. Full OEM or co-development means the product (or platform) is designed or adapted for the partner and may be exclusive. The differences that matter contractually are who holds design documentation, who holds regulatory approval, and what is exclusive.

The regulatory holder is the deal

The single most consequential clause in an IVD OEM contract is who is the legal manufacturer in the regulatory sense. In the EU, the legal manufacturer under the IVDR owns the technical documentation, performance evaluation, post-market surveillance and vigilance reporting; transferring that role to the brand owner requires them to take on those obligations, and the transition deadline regime for legacy devices (running through 2027–2028 by risk class) can constrain re-timing. In the US, the 510(k) holder is the FDA-regulated sponsor of the clearance. Distributor-only deals avoid this transfer; rebranding deals cannot.

Deal structure checklist

Before term-sheet stage, settle: (1) scope — which products, configurations and catalogue numbers; (2) regulatory role — who is legal manufacturer, who holds certificates, who files changes; (3) exclusivity — by market, product line and duration; (4) economics — per-test or per-kit pricing, volume tiers, minimum commitments; (5) supply continuity — lead times, safety stock, last-buy terms; (6) change control — how formulation or packaging changes are notified and who approves them. Every one of these has sunk a deal that started as a friendly sample exchange.

How to shortlist OEM-capable manufacturers

Directories that declare business types make the first cut faster. IVDmap company profiles carry explicit "OEM / ODM" and "CDMO / Private Label" badges alongside the standard manufacturer and distributor types, each profile lists the product records counted from its live catalogue (about 1,500 records across roughly 150 manufacturers as of November 2026), and regulatory labels are shown as manufacturer-reported rather than verified. Shortlist by declared capability and product-family fit, then verify capability the same way you would for any purchase: certificates, references, and a pilot order.

Key takeaways

In IVD, OEM means one manufacturer builds a diagnostic product that another company sells under its own brand; white-label usually means the same finished product rebranded with minimal changes. Deals are structured around four decisions: instrument platform versus assay, who holds the regulatory approval (CE-IVD or FDA clearance), exclusivity, and per-test economics.

  • OEM covers a spectrum: raw reagent supply, finished-kit rebranding, and full instrument-plus-assay platforms.
  • The regulatory holder matters more than the brand: whoever holds the CE-IVD certificate or FDA clearance carries the compliance obligations.
  • Under the EU IVDR, changing the legal manufacturer is a regulatory event, not a paperwork edit.
  • Exclusivity should be scoped by market, product line and duration — never agreed in general terms.
  • Economics are per-test: pricing per reaction or per cartridge decides who profits as volumes grow.

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-11-18

Updated

2026-11-18

Disclaimer

professional use

FAQ

Common questions

What does OEM mean in the IVD industry?

OEM (original equipment manufacturer) in IVD means a diagnostic manufacturer that builds products sold by other companies under those companies' brands. The term covers a spectrum: supplying unbranded reagents, rebranding finished kits, and co-developing instrument-plus-assay platforms sold under the partner's name.

What is the difference between OEM and white-label in diagnostics?

The terms overlap in practice. White-label usually means the OEM's finished product is rebranded with minimal changes and sold as-is. OEM is broader: it can mean co-development, custom configurations, or supplying the core chemistry that the partner integrates into its own system. In both cases, ask who holds the regulatory approval.

Who needs to hold the CE mark or FDA clearance in an OEM deal?

Whichever legal manufacturer places the product on the market carries the regulatory obligation. Under the EU IVDR, the legal manufacturer owns the technical documentation, post-market surveillance and vigilance duties; in the US, the FDA 510(k) holder is responsible for the cleared device. OEM contracts must state explicitly who holds which regulatory role.

How do I find IVD manufacturers that offer OEM services?

Filter directories by declared business type: on IVDmap, company profiles carry "OEM / ODM" and "CDMO / Private Label" badges alongside manufacturer and distributor types, so you can shortlist suppliers that explicitly declare OEM capability, then verify it with their product records and certifications.

Explorar más